Clearmind Medicine Inc.
Clearmind Medicine Inc.
CSE Index:
Currency:
Clearmind develops novel psychedelic medicine based treatments to solve widespread, yet underserved health problems. With solid medical management and IP-protected treatments, the company aims to better the lives of millions of people.
Clearmind Medicine Inc. (CMND)
SEDAR Information
Company Info
Address
101, 1220 W. 6th
Vancouver, BC V6H1A5
CanadaPhone
(604) 260 1566Email
invest@clearmindmedicine.comListing date
Tuesday, May 15, 2018Transfer Agent
Computershare Investor Services Inc.Auditor
Brightman Almagor Zohar & Co.Capitalization
Issued & Outstanding:
2,490,447Reserved for Issuance:
848,206Company Officers
Adi Zuloff-Shani, Chief Executive Officer
Alan Rootenberg, Chief Financial Officer
Bulletins
28/09/2022
2022-0938 – Consolidation - Clearmind Medicine Inc. (CMND)
Le 28 septembre/September 2022
Clearmind Medicine Inc. has announced a consolidation of its issued and outstanding common shares on the basis of one (1) post-consolidated common share for every thirty (30) pre-consolidated common shares.
As a result, the outstanding shares of the company will be reduced to approximately 1,319,744 common shares.
The name and symbol will not change.
Advertisement
Publicité
Upcoming Events
Benzinga Cannabis Capital Conference
Wednesday, September 27, 2023 to Thursday, September 28, 2023
